Improving Reproductive Fitness Through Pretreatment With Lifestyle Modification in Obese Women With Unexplained Infertility
Condition: Infertility, FemaleInterventions: Other: Caloric Restriction; Drug: Orlistat; Other: Moderate exerciseSponsors: Yale University; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Penn State University; Georgia Regents University; University of California, San Francisco; University of North Carolina; University of Oklahoma; University of PennsylvaniaNot yet recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 16, 2015 Category: Research Source Type: clinical trials
Risk Management Plan (RMP) Survey for Purchasers of Alli® (60 mg Orlistat) in the European Union.
Conditions: Obesity; OverweightIntervention: Drug: Alli® 60 mgSponsors: GlaxoSmithKline; CRO: Hamell, The Loft, 1A Salcott Road, London SW11 6DQNot yet recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 16, 2014 Category: Research Source Type: clinical trials
Risk Management Plan (RMP) Survey for Purchasers of Alli® (60 mg Orlistat) in the European Union.
Condition: Weight LossIntervention: Drug: Alli® 60 mgSponsors: GlaxoSmithKline; HamellNot yet recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 15, 2014 Category: Research Source Type: clinical trials
